Dental Health

Dental Health

Dental applications for both wound healing and bone regeneration show a great potential for HS Pharmaceuticals’ silicate-based nanoparticle technology.

Proof of concept clinical pilot studies are being planned that should support our hypothesis for using our platform technology in improving Dental Health.

The initial patent for these applications was filed with the US Patent and Trade Office in April 2016, and HS Pharmaceuticals is currently exploring multiple medical and FDA pathways to bring the technology to market in the dental field.